Overview

18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This prospective study is aimed to evaluate the diagnostic effectiveness of 18F-FLT PET in differentiating benign nature from malignancy for lesions with suspicious or ambiguous findings on mammography or ultrasound; to determine whether 18F-FLT PET or MRI can increase the specificity in breast lesion diagnosis and thus reduce the unnecessary biopsy, and which (18F-FLT PET or MRI) reveals the higher diagnostic performance.
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Alovudine